BTG Pactual Asset Management US »

Intra Cellular Therapies shares owned by BTG Pactual Asset Management US

Quarter-by-quarter ownership of Intra Cellular Therapies (ITCI) shares owned by BTG Pactual Asset Management US from 13F filings

Historical chart of BTG Pactual Asset Management US investment in Intra Cellular Therapies

Tip: Access up to 7 years of quarterly data

All positions including Intra Cellular Therapies held by BTG Pactual Asset Management US consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Intra Cellular Therapies by BTG Pactual Asset Management US

Quarter filed Position value Share count Share price at filing
2025-03-31 $2.0M 15k 131.92

More positions owned by BTG Pactual Asset Management US

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Rus 1000 Grw Etf (IWF)
Vanguard World Mega Grwth Ind (MGK)
Hut 8 Corp Call Option (HUT)
Iren Ordinary Shares (IREN)
Cipher Mining Call Option (CIFR)
Vanguard World Mega Cap Val Etf (MGV)
NVIDIA Corporation (NVDA)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Apple (AAPL)
Alphabet Cap Stk Cl C (GOOG)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Microsoft Corporation (MSFT)
Spdr Gold Tr Gold Shs (GLD)

View all positions for BTG Pactual Asset Management US

Top funds holding Intra Cellular Therapies

Huntington National Bank

View all funds holding Intra Cellular Therapies